UPHALYTE SALTS Malasja - Ingliż - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

uphalyte salts

duopharma manufacturing (bangi) sdn bhd - potassium chloride; sodium bicarbonate; sodium chloride (salt); glucose anhydrous -

ACCUSOL 35 POTASSIUM 4 MMOL/L 4 mMol. Solution for Haemofiltration Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

accusol 35 potassium 4 mmol/l 4 mmol. solution for haemofiltration

baxter healthcare limited - sodium chloride calcium chloride dihydrate magnesium chloride anhydrous sodium bicarbonate potassium chloride glucose anhydrous - solution for haemofiltration - 4 mmol.

Accusol 35 Potassium 4 mmol/lSolution for haemofiltration, haemodialysis and haemodiafiltration Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

accusol 35 potassium 4 mmol/lsolution for haemofiltration, haemodialysis and haemodiafiltration

nikkiso belgium bvba - sodium chloride; calcium chloride; magnesium chloride; sodium bicarbonate; potassium chloride; glucose anhydrous - solution for haemodialysis/haemofiltration - 4 mmol/l - hemofiltrates

Baxter 20 mmol Potassium Chloride, 5% Glucose and 0.45% Sodium Chloride injection for intravenous infusion 1000 mL bag (AHB6024) Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

baxter 20 mmol potassium chloride, 5% glucose and 0.45% sodium chloride injection for intravenous infusion 1000 ml bag (ahb6024)

baxter healthcare pty ltd - potassium chloride, quantity: 1.49 g/l; glucose, quantity: 50 g/l; sodium chloride, quantity: 4.5 g/l - injection - excipient ingredients: water for injections - the potassium chloride, sodium chloride and glucose intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium, potassium and chloride ions in the body fluids. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

Baxter 20 mmol Potassium Chloride, 5% Glucose and 0.9% Sodium Chloride injection for intravenous infusion 1000 mL bag (AHB6066) Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

baxter 20 mmol potassium chloride, 5% glucose and 0.9% sodium chloride injection for intravenous infusion 1000 ml bag (ahb6066)

baxter healthcare pty ltd - potassium chloride, quantity: 1.49 g/l; glucose, quantity: 50 g/l; sodium chloride, quantity: 9 g/l - injection - excipient ingredients: water for injections - the potassium chloride, sodium chloride and glucose intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium, potassium and chloride ions in the body fluids. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

MULTIBIC potassium-free, Solution for Haemofiltration Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

multibic potassium-free, solution for haemofiltration

fresenius medical care australia pty ltd - calcium chloride dihydrate,glucose monohydrate,magnesium chloride hexahydrate,sodium bicarbonate,sodium chloride -

PHYSIONEAL 40 GLUCOSE 1.36 % WV Iżrael - Ingliż - Ministry of Health

physioneal 40 glucose 1.36 % wv

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; glucose monohydrate (as anhydrous); lactic acid as sodium; magnesium chloride hexahydrate; sodium bicarbonate; sodium chloride - solution for peritoneal dialysis - sodium chloride 5.38 g/l; magnesium chloride hexahydrate 0.051 g/l; lactic acid as sodium 1.68 g/l; sodium bicarbonate 2.10 g/l; glucose monohydrate (as anhydrous) 13.6 g/l; calcium chloride dihydrate 0.184 g/l - sodium chloride - sodium chloride - physioneal is indicated whenever peritoneal dialysis is employed including:acute and chronic renal failure severe water retention severe electrolyte imbalance drug intoxication with dialysable substances when a more adequate therapeutic alternative is not available. bicarbonate/lactate based physioneal peritoneal dialysis solutions with a physiological ph are particularly indicated in patients in whom solutions based on lactate buffer only with a low ph cause abdominal inflow pain or discomfort.

PHYSIONEAL 40 GLUCOSE 2.27 % WV Iżrael - Ingliż - Ministry of Health

physioneal 40 glucose 2.27 % wv

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; glucose monohydrate (as anhydrous); lactic acid as sodium; magnesium chloride hexahydrate; sodium bicarbonate; sodium chloride - solution for peritoneal dialysis - sodium chloride 5.38 g/l; glucose monohydrate (as anhydrous) 22.7 g/l; calcium chloride dihydrate 0.184 g/l; lactic acid as sodium 1.68 g/l; magnesium chloride hexahydrate 0.051 g/l; sodium bicarbonate 2.10 g/l - sodium chloride - sodium chloride - physioneal is indicated whenever peritoneal dialysis is employed including:acute and chronic renal failure severe water retention severe electrolyte imbalance drug intoxication with dialysable substances when a more adequate therapeutic alternative is not available. bicarbonate/lactate based physioneal peritoneal dialysis solutions with a physiological ph are particularly indicated in patients in whom solutions based on lactate buffer only with a low ph cause abdominal inflow pain or discomfort.

Accusol 35 Potassium 2 mmol/lSolution for haemofiltration, haemodialysis and haemodiafiltration Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

accusol 35 potassium 2 mmol/lsolution for haemofiltration, haemodialysis and haemodiafiltration

nikkiso belgium bvba - sodium chloride; calcium chloride; magnesium chloride; sodium bicarbonate; potassium chloride; glucose anhydrous - solution for haemodialysis/haemofiltration - 2 mmol/l - hemofiltrates

EFFERVESCENT POTASSIUM CHLORIDE- potassium bicarbonate and potassium chloride effervescent tablets for oral solution tablet, eff Stati Uniti - Ingliż - NLM (National Library of Medicine)

effervescent potassium chloride- potassium bicarbonate and potassium chloride effervescent tablets for oral solution tablet, eff

qualitest pharmaceuticals - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), potassium bicarbonate (unii: hm5z15lebn) (potassium cation - unii:295o53k152), lysine hydrochloride (unii: jnj23q2com) (lysine - unii:k3z4f929h6) - potassium chloride 1.25 g - indications and usage: 1. for therapeutic use in patients with hypokalemia with or without metabolic alkalosis, in digitalis intoxication and in patients with hypokalemic familial periodic paralysis. 2. for prevention of potassium depletion when the dietary intake of potassium is inadequate in the following conditions: patients receiving digitalis and diuretics for congestive heart failure; hepatic cirrhosis with ascities; states of aldosterone excess with normal renal function; potassium-losing nephropathy, and certain diarrheal states. 3. the use of potassium salts in patients receiving diuretics for uncomplicated essential hypertension is often unnecessary when such patients have a normal dietary pattern. serum potassium should be checked periodically, however, and, if hypokalemia occurs, dietary supplementation with potassium-containing foods may be adequate to control milder cases. in more severe cases supplementation with potassium salts may be indicated. contraindications: potassium supp